Medios AG
ISIN: DE000A1MMCC8
WKN: A1MMCC
12 December 2024 01:27PM

EQS-Adhoc: Medios AG: Specification of the full-year forecast

Medios AG · ISIN: DE000A1MMCC8 · EQS - adhoc news
Country: Germany · Primary market: Germany · EQS NID: 2050181

EQS-Ad-hoc: Medios AG / Key word(s): Annual Results
Medios AG: Specification of the full-year forecast

12-Dec-2024 / 13:27 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Adhoc release

 

Disclosure of inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

 

Specification of the full-year forecast

 

Berlin, December 12, 2024 – Medios AG (“Medios”) specifies its full-year forecast as follows: The Company expects revenues of c. €1.85 billion (previous year: €1.8 billion which corresponds to an increase of 2.8%) and EBITDA pre1 of c. €80 million (previous year: €60.5 million which corresponds to an increase of 32.2%). The EBITDA pre1 margin is therefore expected to be around 4.3% (previous year: 3.4 %).

Previously, revenues of €1.9 billion to €2.1 billion and EBITDA pre1 of €82 million to €91 million were expected. Accordingly, an EBITDA pre1 margin of around 4.3% was previously expected.

1 EBITDA is defined as consolidated earnings before interest, taxes, depreciation and amortization. EBITDA pre is adjusted for special charges for stock options and expenses for M&A activities and expenses for ERP-System implementation as well as for one-time performance-based payments for the acquisition of compounding volumes.


Disclosing person: Matthias Gärtner, CEO

End of Inside Information

 

Contact

Medios AG, Heidestraße 9, 10557 Berlin

Telefon: +49 30 232 5668 00; Fax: +49 30 232 5668 01

E-Mail: ir@medios.groupwww.medios.group

-------------------

About Medios AG

Medios is a leading provider of Specialty Pharma in Europe. With locations in Germany, the Netherlands, Belgium and Spain, the company supports key partners in the supply chain with innovative solutions and intelligent services. Medios has focused on pioneering individualized medicine to make the most innovative therapies available to everyone together with pharmacies, specialist practices and pharmaceutical companies.

Medios AG is Germany's first listed specialty pharmaceutical company. The shares are listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and are included in the SDAX selection index.

www.medios.group

 

Contact

Claudia Nickolaus

Head of Investor & Public Relations, ESG Communications

Medios AG

Heidestraße 9 | 10557 Berlin

T +49 30 232 566 800

ir@medios.group

www.medios.group

 

Disclaimer

This communication contains forward-looking statements that are subject to certain risks and uncertainties. Future results could differ materially from those currently anticipated as a result of various risk factors and uncertainties, including, but not limited to, changes in business, economic and competitive conditions, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings and the availability of financing. Medios AG assumes no responsibility to update any forward-looking statements contained in this release.

 



End of Inside Information

12-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Medios AG
Heidestraße 9
10557 Berlin
Germany
Phone: +49 30 232 566 - 800
Fax: +49 30 232 566 - 801
E-mail: ir@medios.ag
Internet: www.medios.ag
ISIN: DE000A1MMCC8
WKN: A1MMCC
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2050181

 
End of Announcement EQS News Service

2050181  12-Dec-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2050181&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2018 2019 2020 2021 2022 2023 2024e
Sales1 327,83 516,80 626,54 1.357,41 1.610,78 1.874,70 1.850,00
EBITDA1,2 8,54 16,37 13,09 34,64 51,21 52,41 64,00
EBITDA-Margin3 2,61 3,17 2,09 2,55 3,18 2,80 3,46
EBIT1,4 7,40 14,39 9,54 15,26 28,97 31,37 35,00
EBIT-Margin5 2,26 2,78 1,52 1,12 1,80 1,67 1,89
Net Profit (Loss)1 4,33 7,76 6,06 7,40 18,33 18,81 19,00
Net-Margin6 1,32 1,50 0,97 0,55 1,14 1,00 1,03
Cashflow1,7 -3,14 -0,45 -38,12 61,52 37,12 16,41 0,00
Earnings per share8 0,31 0,65 0,38 0,37 0,77 0,79 0,72
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Baker Tilly

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Medios
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A1MMCC DE000A1MMCC8 AG 299,95 Mio € 22.11.2016 Kaufen 9F4MG9J9+4H
* * *
PE 2025e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
9,64 32,01 0,30 27,61 0,59 18,28 0,16
Dividends
Dividend '2022
in €
Dividend '2023
in €
Dividend '2024e
in €
Div.-Yield '2024e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
14.08.2024 07.05.2024 13.08.2024 12.11.2024 27.03.2024
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+2,62%
11,76 €
ATH 42,00 €
-16,71% -23,39% -25,85% -24,42% +56,80%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL